News Roche Holding AG

Equities

ROG

CH0012032048

Market Closed - Swiss Exchange Other stock markets 11:31:48 2024-06-06 am EDT			5-day change	1st Jan Change
238.1 ^CHF	+0.85%		+4.29%	-2.62%

06:43am	Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	MT
Jun. 06	AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Buy Recommendation	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	12:43am	MT
AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Buy Recommendation	Jun. 06	MT
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	Jun. 06	DJ
The odds of rates getting cut in 2024 may be better than you think	Jun. 05
ROCHE HOLDINGS AG : Deutsche Bank reiterates its Neutral rating	Jun. 03	ZD
ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Sell rating	Jun. 03	ZD
Astra's Enhertu breast cancer trial shows 'unprecedented' results	Jun. 02	RE
Astra's Enhertu delays breast cancer in patients with low HER2 levels	Jun. 02	RE
ROCHE HOLDINGS AG : Gets a Neutral rating from UBS	May. 31	ZD
Transcript : Roche Holding AG - Shareholder/Analyst Call	May. 31
ROCHE HOLDINGS AG : Goldman Sachs remains a Sell rating	May. 30	ZD
Swiss Stocks Fall as Rate Jitters Intensify Amid Latest Inflation Data	May. 29	MT
Global markets live: BHP, Anglo American, Lenovo, Nvidia, Apple...	May. 29
European Midday Briefing : Mood Sours as Fed Rate-Cut Bets Curtailed	May. 29	DJ
Roche: FDA grants priority review in breast cancer	May. 29	CF
Roche's Metastatic Breast Cancer Treatment Granted Priority Review by US FDA	May. 29	MT
Roche Breast-Cancer Drug Gets Priority Review in the U.S.	May. 29	DJ
FDA Grants Priority Review to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With a PIK3CA Mutation	May. 29	BU
Roche Holding AG Announces U.S. Food and Drug Administration Accepted the New Drug Application and Granted Priority Review to Inavolisib, an Investigational, Oral Therapy, in Combination with Palbociclib (Ibrance®) and Fulvestrant	May. 29	CI
Roche and Hitachi High-Tech extend their long-standing partnership	May. 28	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am EDT

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST